LupusTrials.org First posted May, 2021, Updated September, 2021; Recruiting CATEGORIES: Lupus The purpose of this Phase 3 study is evaluating the efficacy and safety of SC anifrolumab in adult patients with moderate -to-severe SLE despite receiving standard therapy. To Learn More Contact AstraZeneca Clinical Study Information Center at 1-877-240-9479 or email information.center@astrazeneca.com ClinicalTrials.gov identifier (NCT number): …
Tag: anifrolumab
Lupus Expert Dr. Richard Furie Addresses Clinical Trials
June 12, 2019 As reported by The Rheumatologist, Dr. Richard Furie provided his perspective on clinical trials in lupus in a talk for the American College of Rheumatology meeting. “Lupus is being attacked in a very eclectic manner. It’s just fascinating to me how many different approaches are being taken to attack this condition,” he …